Intervet/Schering-Plough Animal Health appoints Executive Team

THE NETHERLANDS – Schering-Plough appointed the Executive Team members of the company’s global animal health unit: Intervet / Schering- Plough Animal Health. These appointments define the major steps in the design process of the animal health unit. The executive team is chaired by Ruurd Stolp, Senior Vice President and President Animal Health. Dr. Stolp reports to Fred Hassan, chairman and CEO, Schering-Plough.
calendar icon 15 May 2008
clock icon 5 minute read

MSD Animal Health - NYSE:MRK

Appointed as Executive Team Members are:

Raul Kohan, Senior Vice President, Corporate Excellence and Deputy Head Animal Health;

Mr. Kohan has been an executive at Schering-Plough since 1984, rising through a variety of roles in the company, and has held the position of Group Head Global Specialty Operations (Consumer and Animal Health) and most recently President of Schering-Plough Animal Health and Senior Vice President of the Corporation. Prior to joining Schering-Plough, Kohan was employed by Pfizer Inc., where he served as controller and budget and economic analysis director of the company’s Argentine operations and treasurer of its Latin American region. Kohan graduated from the General San Martin Military Academy, Argentina, and holds a MBA degree in economics from the University of Buenos Aires, Argentina. Mr. Kohan is a member of the corporate Executive Management Team. In his role as Senior Vice President Corporate Excellence, he is reporting to Fred Hassan, chairman and CEO, Schering-Plough.

Hugo Wahnish, Vice President, Global Animal Health Regions;

Hugo Wahnish has held the position of Vice President, EUCANA region (Europe-Canada-Middle East Africa-Australia and New Zealand) at Schering-Plough Animal Health since 2003. He joined Schering-Plough in 1994 as Sr. Director, Worldwide Business Development. In 1997, he was appointed Vice President, Global Marketing and Business Development and in 1999 he became Vice President Latin America & Worldwide Marketing. Prior to joining Schering-Plough, Mr. Wahnish held various sales and marketing positions of increasing responsibility with Glaxo-SmithKline Beecham. Mr. Wahnish holds a MBA degree in International Marketing and a Bachelors degree in Economics/Finance. Hugo Wahnish is reporting to Ruurd Stolp.

René Aerts, Vice President, Animal Health, Research and Development Biologicals;

Dr. Aerts was Director of Operations for Intervet International in the Netherlands since 2006. Prior to this, he was Director of R&D in the Netherlands for a three year period. Since joining Intervet in 1990, Dr. Aerts held a variety of roles with increasing responsibility, including Director of Regulatory Affairs (Biologicals) and Head of Antibiotics R&D. He holds a MSc in Pharmaco-Chemistry and Organic Chemistry from the Radboud University of Nijmegen, the Netherlands and a Ph.D. in Bioanalytical Chemistry from the Free University, Amsterdam, the Netherlands. Dr. Aerts is reporting to Ruurd Stolp.

K.J. Varma, Vice President, Animal Health, R&D Pharmaceuticals;

Dr. Varma has held the position of Vice President Global Research & Development at Schering-Plough Animal Health since 1997. He joined Schering-Plough in 1985 and has held various research positions in Animal Health of increasing responsibility. Prior to joining Schering-Plough, Dr. Varma spent five years at College of Veterinarian Medicine at The Ohio State University in research and teaching. Dr. Varma holds a DVM, MS and PhD in Pharmacology and obtained ACVCP Board Certification in Clinical Pharmacology from The Ohio State University. Dr. Varma is reporting to Ruurd Stolp.

Jochen Bader, Vice President, Global Finance, Animal Health;

Mr. Bader has held the position of Vice President, Finance and Control, Intervet in Boxmeer. He began his career with Hoechst Roussel Vet in the finance department were he held various roles of increasing responsibility, including an assignment in South Africa and a financial controller position in the UK. After the acquisition of Hoechst Roussel Vet by Intervet, he held General Manager positions in India and Taiwan and became Director and later Vice President Finance and Control of Intervet in Boxmeer. Mr. Bader holds a degree in Business Administration “Dipl. Betriebswirt (FH)” (University of Applied Sciences), Landshut, Germany. Mr. Bader reports to Robert Bertolini, Executive Vice President and Chief Financial Officer, Schering-Plough.

Malte Greune, Vice President Global Supply Chain Animal Health;

Dr. Greune has held the position of Director, Global Manufacturing Pharma and Biologicals and vice president, Manufacturing and Logistics and was a member of Intervet’s Executive Committee. He began his career with Hoechst AG in Frankfurt, Germany in manufacturing. After finishing his study of Business Administration at the Clark University, USA, and ‘Diplom-Kaufmann’ at the University of Trier, Germany, Dr. Greune received his doctoral degree from the University of Cologne. He received a number of awards for his achievements, among other things a ‘DAAD-Scholarship’, USA, and was supported by the German National Merit Foundation. Dr. Greune is reporting to Ian McInnes, Senior Vice President, GSC Schering-Plough.

Mark van Heumen, Law Lead Global Animal Health;

Mr. van Heumen joined Schering-Plough from Organon BioSciences, where he was Executive Director, Legal Affairs, Intervet. He joined Intervet in 1999 from Akzo Nobel, where he was senior legal counsel and provided legal advice to Organon and Intervet. Early in his career, Mr. van Heumen held positions in Organon Teknika’s law and licensing departments in Belgium. Mr. van Heumen is reporting to Tom Sabatino, Executive Vice President and General Counsel Schering-Plough.

Andreas König, Vice President, Global Quality Operations, Animal Health;

Dr. König has held various roles of increasing responsibility with Intervet, including head of Quality Operations Pharma and Global Quality director, He began his career with Fresenius AG in Bad Homburg, Germany, in the Quality Control and Quality Assurance department. Dr. König received his doctoral degree from the University of Würzburg, Germany. He is reporting to Richard S. Bowles, Ph.D., senior vice president, GQO, as QLT.

Gráinne Higgins, Vice President, HR, Animal Health;

Ms. Higgins joined Schering-Plough in 1997 following the global acquisition of Mallinckrodt Veterinary. She has held the position of executive director, HR, Global Pharmaceutical Business, EUCAN Region II and prior to that led the HR team for Global Functions. Earlier in her career, Ms. Higgins held several positions of increasing responsibility including director, HR, Global Supply Chain and Global Quality Operations. Ms. Higgins has a MSc in Organization Behavior from Trinity College, Dublin, Ireland and a National Diploma in Personnel Management from the National College of Industrial Relations, Ireland. She graduated with honors from University College Dublin, where she earned a Bachelor of Social Science degree. Gráinne Higgins is reporting to C. Ron Cheeley, Senior Vice President, Global Human Resources, Schering-Plough.

The new combination Intervet / Schering-Plough Animal Health strengthens the animal health portfolio in several areas and brings together complementary lines of pharmaceuticals, biologicals and innovative services. Intervet / Schering-Plough Animal Health is not only the world market leader in the production of animal health vaccines, but is also one of the world’s leaders in the field of animal health—with offices in more than 50 countries and products marketed in over 120 countries.

TheCattleSite News Desk More MSD Animal Health News
© 2000 - 2024 - Global Ag Media. All Rights Reserved | No part of this site may be reproduced without permission.